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Prenatal alcohol exposure is associated to different physical, behavioral, cognitive, and
neurological impairments collectively known as fetal alcohol spectrum disorder. The
underlying mechanisms of ethanol toxicity are not completely understood. Experimental
studies during human pregnancy to identify new diagnostic biomarkers are difficult to
carry out beyond genetic or epigenetic analyses in biological matrices. Therefore, animal
models are a useful tool to study the teratogenic effects of alcohol on the central
nervous system and analyze the benefits of promising therapies. Animal models of
alcohol spectrum disorder allow the analysis of key variables such as amount, timing
and frequency of ethanol consumption to describe the harmful effects of prenatal alcohol
exposure. In this review, we aim to synthetize neurodevelopmental disabilities in rodent
fetal alcohol spectrum disorder phenotypes, considering facial dysmorphology and fetal
growth restriction. We examine the different neurodevelopmental stages based on the
most consistently implicated epigenetic mechanisms, cell types andmolecular pathways,
and assess the advantages and disadvantages of murine models in the study of fetal
alcohol spectrum disorder, the different routes of alcohol administration, and alcohol
consumption patterns applied to rodents. Finally, we analyze a wide range of phenotypic
features to identify fetal alcohol spectrum disorder phenotypes in murine models,
exploring facial dysmorphology, neurodevelopmental deficits, and growth restriction,
as well as the methodologies used to evaluate behavioral and anatomical alterations
produced by prenatal alcohol exposure in rodents.
Keywords: prenatal alcohol exposure, fetal alcohol spectrum disorders, fetal alcohol syndrome, alcohol
consumption patterns, facial dysmorphology, neurodevelopmental disorders, fetal growth restriction, models of
fetal alcohol spectrum disorders
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INTRODUCTION
Alcohol is a known teratogen. Its frequent use during pregnancy
impacts the normal development of human fetuses promoting
severe developmental alterations and generating a wide range of
physical, behavioral, cognitive, and neurological impairments. In
1968, Lemoine et al. established an association between prenatal
alcohol exposure (PAE) with certain neurodevelopmental
disabilities (1). However, it was not until 1973 when Jones
and Smith provided the initial characterization of fetal alcohol
syndrome (FAS) (2), defined as growth restriction, facial
dysmorphologies (wide-spaced eyes, mid-facial hypoplasia, and a
smooth philtrum), and central nervous system (CNS) disorders,
resulting in motor, cognitive and behavioral disorders (3).
Subsequent observational studies identified and characterized
the umbrella term fetal alcohol spectrum disorder (FASD) (4)
that includes: FAS (the most deleterious manifestation of FASD),
partial FAS (pFAS) (an intermediate phenotype defined by
the absence of some FAS characteristics), alcohol-related birth
defects (ARBD) (certain physical impairments are exhibited), and
alcohol-related neurological disorders (ARND) (behavioral and
learning neuropsychological alterations, usually without facial
dysmorphology) (5).
Thus, behavioral deficits in FASD subjects associate with
structural changes in brain organogenesis: the Corpus callosum
may lose its structure (agenesis) and generate cognitive deficits
linked to attention, executive and psychosocial functions,
language, and reading comprehension (6); cerebellum and
anterior part of the vermismay suffer hypoplasia and affectmotor
skills and learning capacity (7). Moreover, proven asymmetry of
the hippocampus in FAS children may also affect their memory
(8). The degree of structural abnormalities in the brain correlates
with the severity of FAS-like facial features, and this in turn, with
more serious behavioral problems (9).
According to theWorld Health Organization, PAE is the main
preventable cause of intellectual disability in the western world
(10–12). A recent meta-analysis estimated global prevalence
of alcohol use during pregnancy to be 9.8% (13). Therefore,
PAE-related disorders may lead to major problems for the
social environment as well as economic setbacks for the public
health system.
Animal models play a key role in the study of FASD by
allowing the development of novel diagnostic and therapeutic
tools. Researchers have used a great variety of organisms
to mimic the physical and behavioral characteristics found
in PAE and FASD phenotypes. Inbred strains of rodents
are genetically homogenous populations that facilitate
result reproducibility and interpretation in studies designed
to evaluate the impact of environmental insults such
as ethanol. Moreover, the alcohol intake pattern can be
more precisely defined (timing and dose), allowing the
identification of time-sensitive windows and thresholds
of harmful doses during pregnancy. Rodents have been
widely used in FASD research to assess the way PAE-related
impairments affect metabolic pathways, molecular biology,
cell signaling, synaptic plasticity, and cognition during fetal
development, promoting the study of variables affected by
alcohol exposure at neuroanatomical, neurochemical and
behavioral levels (14).
In this review, we focus on rodent FAS-like phenotype
neurodevelopmental disabilities, taking into account facial
dysmorphology and fetal growth restriction. We examine every
stage of brain development, considering changes caused by
PAE in different neural cell lineages, molecular pathways
and oxidative stress epigenetic variations. We also review the
experimental methodologies used to generate rodent FASD-
like phenotypes, including advantages and disadvantages of the
different routes by which alcohol has been administered. Finally,
we revise anatomical and behavioral alterations, as well as the
methodologies used to assess these features in murine models.
FASD-LIKE ANIMAL MODELS
FASD studies in humans have common limitations due to the
complexity in correctly measuring certain variables such as
maternal diet or health, or the volume and timing of ethanol
exposure during pregnancy. These difficulties may be resolved
by using animal models, simple, effective, and reliable tools for
alcohol research. These models are useful for understanding
the molecular mechanisms underlying alcohol teratogenicity
and for monitoring cognitive and behavioral changes. Animal
models also allow assessing different therapeutic approaches in
preclinical studies, for initial screening of the compounds and
strategies for future human clinical studies.
The invertebrate Caenorhabditis elegans is a simple model for
development and is commonly chosen to study the effects of
ethanol on molecular pathways. However, the embryos develop
outside the body, exact ethanol concentrations administered
cannot be finely controlled (15), and the way alcohol is
metabolized differs substantially from that in humans (15). The
zebrafish (Danio rerio) has several physiological and genetic
similarities with humans (16), which makes it a suitable
alternative as model of vertebrate. Regarding the effects of
ethanol, there are further advantages: substantial knowledge of all
stages of development, short developmental period, and produce
large amounts of offspring (17). Zebrafish eggs and embryos
are transparent (just like in nematodes) making embryonic
development easy to follow, facilitating exposure to alcohol of
the embryos during different and precise developmental periods,
and easy determination of physical malformations and simple
behaviors (16, 18). By contrast, the chorion of the egg acts as a
barrier and large volumes of ethanol are necessary to ensure its
penetration (17).
Mammals offer significant advantages in the study of brain
structures or complex behaviors (19). Although primates could
be the gold standard, there are some disadvantages, mainly
the long duration of the studies and ethical limitations (19).
Rodents are the most employed mammals for FASD research
because they are easy to handle, have a short gestational
period, and produce large numbers of offspring. Rats offer
the advantages of being larger and with a more sophisticated
behavior in comparison to mice. Regardless, mice (particularly
the C57BL/6 strain) are the most commonly used mammal
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due to their ease of care, availability of transgenic and disease
models, short lifespan, and basic physiology and genetics similar
to that of humans. Teratogenic effects of alcohol exposure in
mice have been reported, including craniofacial malformations,
altered neurogenesis processes, and soft-tissue and skeletal
abnormalities (20, 21). The main disadvantage in using rodents
for FASD research is that the third trimester equivalent to
human development in rodents occurs after birth. Thus, there
are differences in the processes of absorption, distribution,
metabolism and elimination in rodents in comparison to the
human utero, with no influence of the placental barrier.
Interestingly, C57BL/6J is the strain with the highest preference
for alcohol (22).
In following sections, we discuss details that need to be
considered when a murine model is chosen for a FASD study.
Alcohol Exposure Patterns
Drinking patterns are characterized by the amount and
frequency of ethanol taken. This is measured by blood alcohol
concentration (BAC) and expressed as weight of alcohol per unit
of volume of blood.
Kelly et al. showed that binge-like alcohol exposure is more
harmful than non-binge exposure in rat brain development after
exposure to the same dose of ethanol. The authors administered
doses of 6.6 g/kg/day of ethanol to neonatal rats using artificial
rearing, following one of two possible patterns. A continuous
pattern (24 h per day) for several days, which resulted in an
average BAC peak of 79–97mg/dL or an acute exposure pattern
(8 h per day) for the same period of time, resulting in an average
BAC peak of 56–415mg/dL. Lower brain growth was observed
in the acute exposure group in comparison to the continuous
pattern (23). Other findings support the hypothesis that lower
daily doses of ethanol following a binge-like pattern leads to
lower brain weight and cell loss in different brain areas than
higher non-binge doses. Three groups of ethanol-exposed rat
pups were compared. One group was exposed to 4.5 g/kg/day in a
condensed pattern (4 h per day), the second group was exposed to
the same dose although administered in a less condensed pattern
(8 h per day), and the third group was exposed to a higher dose of
alcohol (i.e., 6.6 g/kg/day) administered in a continuous pattern
(24 h per day). The resulting average BACs peaks were 361, 190,
and 39mg/dL, respectively. The authors found that pups exposed
to 4.5 g/kg/day over 4 h had the lowest brain weight, followed
by the second group. The animals that ingested highest doses of
ethanol throughout the 24 h had the highest brain weights (24).
These results demonstrate that ethanol intake under a binge-
like pattern is more harmful than higher doses taken for longer
periods of time due to higher BAC peaks in shorter periods
of time.
Control Group
Several studies have assessed the influence of nutritional intake
on the teratogenic effects of alcohol (25, 26). Alcohol can replace
other nutrients because of its caloric content and may interfere
with the absorption of other nutrients due to its inflammatory
effects on the stomach (27).
Pair-fed control has been used in some FASD-like animal
model experiments since it acts as a calorie-matched control
group. A carbohydrate substance (e.g., maltose dextrin or
sucrose) is usually employed to replace ethanol-derived calories
in the diet (28). A pair-fed group may also allow monitoring
a stress condition. On the other hand, the pair-fed group is
considered as an imperfect control group, since the pattern of
food consumption in this group is different from a physiological
intake. Individuals in pair-fed controls consume the assigned
food as soon as it is available, creating additional stress associated
to food restriction. In addition, in the pair-fed group it is not
possible to match the effect of alcohol on the absorption of
other nutrients because of its inflammatory effects. Thus, some
researchers have suggested the use of a basal control group
known as non-handle, ad libitum, or sham, in which the intake of
nutrients resembles the physiological one. This is useful to avoid
biases caused by ethanol interference in nutrient absorption (29).
Consequently, the use of a pair-fed group and an ad libitum
control group should be considered as an alternative when
designing a FASD murine model study.
Route of Administration and Dosage Forms
Several modes of ethanol administration methods have been
described, particularly in rodent gestation. Ethanol delivery
methods directly affect variables such as the alcohol exposure
pattern, exact amount of alcohol taken, and generated stress. All
these variables must be taken into account during experimental
design. Voluntary ethanol feeding and intragastric gavage are the
most physiological administration methods. Voluntary ethanol
feeding (30, 31) is a safe technique when low stable BAC levels
want to be reached. Conversely, intragastric gavage (29) offers a
more accurate control of doses and timing, and reaches higher
BACs. Inhalation (32) or injection (33) offer some advantages
compared to voluntary ethanol drinking and intragastric gavage
due to their time efficiency. Artificial rearing is a useful method
when the aim of the study is alcohol administration in a third
trimester equivalent model (29, 34, 35). Briefly, the choice of
method must consider the purpose of the experiment and the
researcher’s experience. Table 1 [based on a previous review (45)]
summarizes the characteristics of the main routes of alcohol
administration in rodents and dosage forms, focusing mainly
on mice.
Blood Alcohol Concentration
BAC depends on several factors such as dosage, pattern of
exposure, metabolic rate, food consumption, tolerance and
genetics (46, 47). As mentioned above, BAC peaks are higher
when ethanol is administered in a binge-like pattern, even with
low doses of alcohol (24). There are several types of methods
for measuring BAC: headspace gas chromatography (HS-GC),
headspace solid-phase microextraction (HS-SPME), capillary
gas chromatography, or enzymatic ADH immunoassays (48).
Immunoassays are not as accurate as mass spectrometry and are
susceptible to bias by overestimating alcohol concentration due
to non-specific interferences. On the other hand, immunoassays
are sufficiently accurate, easy to use in any laboratory, and
require a small amount of sample (∼100 µL). Immunoassays
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TABLE 1 | Characteristics of the different routes of ethanol administration in mice.
Administration
route




Pre-gestational alcohol consumption is
usually introduced (36).
Sometimes, ethanol is added to flavored
liquid nutritional formulas (Liquid-diet or
Sustacal) to allow easy
self-administration (37, 38).
10–20% (vol/vol) ethanol solution (36).
Possibility of isovolumic and isocaloric
pair-fed diet (e.g., maltose-dextrin) in
controls (28).
Drinking in the dark (DID) procedure
mimics binge-like pattern (39).
50–100mg/dL when
ethanol intake is 1–2 g/Kg
[10% (vol/vol) ethanol
solution]
Prevent the stress caused
by other invasive methods.
Safe technique.
Easy to carry out.
Gradual BAC increase.
Low, stable BAC levels.
Used prenatally.
Lower ethanol BAC achieved
compared to other administration
routes.
Not useful for binge drinking pattern.
Difficult control of dose and timing.
No proper control of dose in
breastfeeding pups.
Not recommended postnatally.
Lower BAC achieved if saccharin or a




Administration of ethanol into the
stomach using a gavage needle.
Administered volumes <2 mL/100Kg
body weight (40).
Allowed alcohol concentration <31.5%
(vol/vol) (40).
Ethanol dose 2–6 g/Kg/day (28).




3.8 g/Kg [21% (wt./vol)
ethanol solution]
Useful for binge drinking
pattern.
Accurate control of dose
and timing.
Reliable high BAC.
Useful for pre- and
postnatal administration.
Inhibition of suckling behavior in
neonates.
Stressful procedure for animals.
Invasive procedure.
Inhalation Inhalation chamber filled with ethanol
vapor (41).
Sometimes, administration of pyrazole to
obtain stable BACs (32, 42).
150–250mg/dl when
volatized ethanol (ethanol
95%) is delivered to the
chamber at a rate of 10 l/min
Reliable high BAC.
Not a stressful technique for
animals.
Time and labor efficient.
Useful for pre- and
postnatal administration.
Higher BACs in neonates
compared to mothers.






Ethanol solution injection in
intraperitoneal space (43).




3.8 g/Kg [21% (wt./vol)
ethanol solution]
Rapid increase in BAC.
Time efficient.





Different intake routes in humans.
This administration route produces
higher BAC in fetuses than other
routes using the same PAE.
Higher incidence of malformations
when used during first
trimester equivalent.
Artificial rearing Intragastric gavage ethanol discharge in
pups while being kept in a special
setting to mimic maternal environment
(29, 34, 44).
Placement of gastrostomy catheters.
150mg/Kg when ethanol
solution of 2,5 g/Kg is
administered or 420mg/Kg
when ethanol solution of
7,5 g/Kg is administered*






Invasive and expensive technique.
Social factors removed due to
isolation of pups.
*Data obtained from experiments with rats (no available data for mice). BAC, blood alcohol concentration; Vol, volume; Wt, weight.
are currently the most commonly used method for determining
BACs in peripheral blood.
In animal models, BAC is defined as the amount of ethanol
per unit of blood (usually mg/dL), measured when ethanol
concentration reaches the highest level in peripheral circulation
(49). In rodents, peak concentration is detected between 30
and 150min (50–100min in mice and 50–150min in rats)
following administration. The timeline of BAC depends on
the administration route, the dosage and the species (rate
of ethanol metabolism is 550 and 300mg/Kg/h in mice and
rats, respectively) (50). Severe neurotoxicity is typically linked
to binge-like episodes causing higher BACs (i.e., BAC over
300mg/dl in rats). However, continuous alcohol exposure,
reaching lower BAC levels (i.e., BAC below 40mg/dl in rats)
despite higher doses, induces more subtle brain injuries (23, 24).
DEVELOPMENTAL STAGES OF THE FETAL
BRAIN
During the development of the CNS throughout pregnancy, there
are vulnerable periods sensitive to environmental insults. PAE
affects brain organogenesis differently depending on the dosage,
timing, developmental stage (moment), and location of the cell
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FIGURE 1 | Timeline of neurodevelopmental processes and brain neurogenesis in fetal rodents by areas sensitive to alcohol injury. Proteins in neurulation,
proliferation, migration, differentiation, synaptogenesis, gliogenesis, and myelination neurodevelopmental processes. Changes in the levels of these biomarkers (up- or
down-regulation) caused by prenatal alcohol exposure are represented by arrows. Stages of neurulation: (1) Neuroectodermal tissues differentiate from the ectoderm
and thicken into the neural plate. The neural plate border separates the ectoderm from the neural plate. (2) The neural plate bends dorsally, with the two ends
eventually joining at the neural plate borders, forming the neural crest. (3) The closure of the neural tube disconnects the neural crest from the epidermis. Neural crest
cells differentiate to form the peripheral nervous system.
types involved in the biological stages (Figure 1). Key processes
such as proliferation (51), migration (52), differentiation (53),
synaptogenesis (54, 55), gliogenesis, myelination (56), and
apoptosis (57, 58) are altered by PAE leading to congenital
abnormalities and functional deficits in the CNS during fetal
development (Figure 2) (74, 75).
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FIGURE 2 | Harmful effects of prenatal alcohol exposure in mice according to human trimesters equivalents (59). First trimester equivalent: cranial dysmorphologies
(60, 61), brain malformations (61, 62) and altered gray and white matter tracts (63). Second trimester equivalent: craniofacial and brain malformations (62, 64, 65),
neurodevelopmental disorders (66, 67) and fetal growth restriction (68, 69). Third trimester equivalent: brain abnormalities (70–72), neurodevelopmental disorders
(71, 73). GD, gestational day. PND, postnatal day.
The anatomies of human and rodent brains show analogous
structures and similar stages of development. However, they
also exhibit some anatomical and functional differences. Human
pregnancy consists of three pre-natal trimesters in which
the brain rapidly grows between week 25 and 38. Several
differentiation and proliferations processes occur in the third
trimester of gestation, with maximum brain growth rate at birth
and gradual decrease in early life (59, 76). Rat and mouse
pregnancies are shorter than human pregnancies (rats: 21–23
days; mice: 20–22 days) and newborns undergo substantial brain
development following birth (56, 57). The first trimester (59) in
human pregnancy corresponds to gestational days (GDs) 1–10/11
in rat andmouse. The second trimester equivalent corresponds to
GDs 11–21/22 (mice usually give birth on GD 21 and rats on GD
22), and the third trimester equivalent correlates to postnatal days
(PNDs) 1–10. The ontogeny of specific behaviors can be used
to draw inferences regarding the maturation of specific brain
structures or neural circuits in rodents and humans. Despite the
similarities between human and rodent brain development it is
important to consider that rodents do not exactly mimic the
developmental phases of human gestation (Figure 1).
Cellular precursors of the brain and the spinal cord develop
through neurulation in early embryogenesis (Figure 1). The
cellular fate of neurulation is the formation of the notochord,
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which defines the primitive axis of the embryo and determines
the vertebral system. The neural tube closure starts in the
hindbrain area above the origin of the notochord, and continues
anteriorly and posteriorly, making a caudal-to-rostral gradient
in the developing brain. Neural tube formation finishes at
gestational day (GD) 10–11 in rodents (77). Early in the second
week of pregnancy (GD 7 in mouse, GD 9.5 in rats), neurogenesis
and subsequent cell migration shape specific areas of the CNS
in the forebrain, midbrain, and hindbrain, promoting distinct
series of developmental processes (77). Therefore, the second
critical developmental stage for PAE occurs between GD 5 and
11, implying alterations in organogenesis, neural tube formation
and proliferation of neuronal precursors in areas adjacent to the
neural tube. High levels of alcohol exposure during this stage
not only cause major neural tube defects, but also lead to facial
dysmorphologies similar to those observed in children affected
with FAS.
The second critical developmental stage occurs between
GD 11 and 21. During this period, most CNS areas are
involved in distinct differentiation processes and several neuronal
cell types emerge and migrate to specific areas of the brain
(including the cerebral cortex and the hippocampus; Figure 1).
The developmental phase of the different cell lineages varies
according to its spatial location in separate brain areas. PAE
particularly affects the neurulation, proliferation, and migration
processes of the neocortex, cerebellum, hippocampus, and the
basal ganglia. The last decisive developmental period occurs
from GD 18 to postnatal day (PND) 9 and is characterized
by the proliferation of astroglial and oligodendroglial cells,
synaptogenesis, and dendritic arborization, which produce an
increase in brain weight. At the same time, neurogenesis
continues in the cerebellum and the dentate gyrus (DG) of the
hippocampus. Alcohol exposure during third trimester induces
severe neuronal loss, reactive gliosis, impaired myelination,
as well as damage to the prefrontal cortex, hippocampal and
cerebellar regions (64, 78, 79).
Proliferation
Neurogenesis is a highly regulated process whose timing and
phases depend on the anterior-posterior gradient in the neuronal
axis and the regions of the brain formed during organogenesis.
Most cell proliferation processes take place throughout all the
stages of neurodevelopment (80), although the most expansive
phase occurs in the second half of pregnancy (mice: GD
10–21, rats: GD 11–22). This is a key developmental period
due to ethanol toxicity vulnerability of neuronal precursors
and brain structures (51), which may cause permanent
alterations and profound behavioral deficits. For that reason,
the consequences of PAE on proliferation and differentiation
processes are assessed not only during fetal development but
also later in life. As shown in Figure 1, several biomarkers help
identify and evaluate neurogenesis and proliferation processes
during neurodevelopment.
NeuN is expressed in nearly all post-mitotic neurons
representing a reliable marker of mature neurons (81). This
protein may also act as a biomarker of neuronal integrity, as it
decreases in brain regions such as the hippocampus following
ethanol exposure in rats (81–83). Ki67 has been thoroughly
analyzed as a proliferation biomarker during neurogenesis in
PAE studies.
Several authors have studied the effect of PAE on different
regions of the hippocampus with different results. Some have
found a reduced number of granular cells in the DG and
pyramidal cells in specific regions of the rat hippocampus after
GD 1–GD 20 plus PND 4–10 of ethanol exposure (24, 84), and
during the third trimester equivalent (24, 83, 84), with no changes
in the number of hippocampal neurons after GD 1–20 ethanol
exposure (84, 85). Komada et al. showed a reduced proliferation
rate (measured by Ki67) in mouse telencephalon after PAE on
GD 6–18 (86). Conversely, West et al. showed an increase in
the number of granular cells of the DG in rat hippocampus
after ethanol exposure during the third trimester equivalent (87).
Thus, early disturbances in proliferation after PAE may differ
depending on the developmental period in which exposure to
ethanol occurs.
Some of the effects of PAE on the hippocampus can be
identified from birth, but others are more subtle and difficult
to detect in the early stages. The consequences of PAE on
hippocampal cell proliferation and survival in young adult
animals are not always persistent (29, 35, 88). Interestingly,
no changes in hippocampal cell proliferation (assessed by Ki67
and BrdU), but an increase in immature neurons of adult
hippocampus in rats prenatally exposed to alcohol, have been
described, probably due to a compensatory mechanism against
PAE effects (29). Other authors have shown alterations in cell
proliferation [measured by Ki67 (35) and BrdU (35, 88)] and
increased neuronal maturation in the DG of the hippocampus
in young adult rats prenatally exposed to ethanol. More recently,
Gil-Mohapel et al. described significant decreases in adult
hippocampal neurogenesis in aged rats after PAE (during first
and second trimester equivalent), not previously seen in younger
animals. These findings suggest a more conserved neurogenesis
capacity in the early stages of life (89). Moreover, Delatour
et al. analyzed Ki67 levels in pyramidal cells in adolescent mice
exposed to ethanol at GD 13.5–16.5 and showed there were no
changes when compared to controls (90). Once again, it seems
that alterations in hippocampal neurogenesis vary according to
the timing of ethanol exposure.
Coleman et al. examined the long-term effects on adult
hippocampal neurogenesis after ethanol exposure in PND 7 in
male and female mice. Increased Ki67 levels were found in
the DG in males but not in females (70). This reveals gender
differences regarding susceptibility to PAE.
PAE also affects the activity of enzymes involved in
neurogenesis and proliferation, promoting hippocampal
function behavioral disorders. Glycogen synthase kinase-
3β (GSK3β) is highly expressed during brain development
[from GD18 to PND10 in rats (91) and GD16 to PD18 in
mice (92)] modulating different developmental processes
such as neurogenesis, differentiation and neuronal survival.
GSK3β activation sensitizes neurons to ethanol-induced injury,
deregulating cell proliferation mechanisms (93). Increased levels
of GSK3β post-PAE activates apoptosis in neural progenitor
cells, decreasing neurogenesis and differentiation in immature
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brains. Additionally, ethanol decreases the insulin-like growth
factor (IGF) receptor signaling, affecting neural proliferation and
decreasing the transcription of c-myc, c-fos, and c-jun51 in cell
cultures (94).
Current evidence indicates that prenatal and neonatal alcohol
exposure reduces the number of mature and immature neurons.
Interestingly, this reduction is subtle when ethanol exposure is
not continuous. Nonetheless, the brain region, developmental
stage, and cell type are key factors when analyzing results of the
biomarkers in proliferation processes.
Migration
Migration from the ventricular and germinal layers occurs
radially in the medial/dorsal neocortex and tangentially in
other regions of the forebrain (95). On GD 5, superficial
layers are still not clearly defined (96). On GD 14.5 (mice)
or GD17 (rats), the first cell lineages reach the area that
will form the laminae of the cortical plate. Throughout the
rest of the gestation period until adulthood, the cortical plate
gets thicker and more cells migrate from the ventricular zone
(97). When proliferation is disrupted, migration is also affected
(Figure 1). PAE alters proliferation and migration processes
(52), affecting neural crest migration and causing cytoskeletal
rearrangements. These phenomena destabilize the formation
of focal adhesions in cell lineages, reducing their capacity for
directionalmigration.Moreover, the activity of glycogen synthase
kinase 3 (GSK3) and cyclin-dependent kinase 5 (cdk5) modulate
microtubule-associated protein 1B (MAP1B) phosphorylation,
involved in the regulation of microtubules and actin filaments
in neurons, needed in migration processes (98). In vitro, ethanol
inhibits neurite outgrowth by activating GSK3β (99). Conversely,
PAE promotes GABAergic interneuron migration by inducing
epigenetic alterations in the methylation pattern of the MeCP2-
BDNF/DLX5 pathway. MeCP2 regulates the expression of the
brain-derived neurotrophic factor (BDNF), a marker of neuronal
plasticity and cellular survival known to influence GABAergic
interneuron migration (100). MeCP2 has been shown to regulate
DLX5 transcription, a transcription factor involved in the
migration and maturation of GABAergic interneurons in mouse
models (101). The human natural killer-1 (HNK-1) carbohydrate
is also used as a biomarker in migration processes studies
involving cranial neural crest cells (102). Results indicate reduced
levels of HNK-1 in a model of chick embryos exposed to 2%
ethanol, which suggests that PAEmay disrupt cranial neural crest
cell migration.
Long-term effects of PAE on migration have also been
evaluated. Miller et al. describe the harmful effects of alcohol
on proliferation and migration in rats prenatally exposed to
alcohol. The authors found a delay in migration of early and late-
generated neurons in rats following PAE between GD 6 and GD
21. Ethanol blocks neuronal migration, probably by leading to
a desynchronization of cortical development that interferes with
the establishment of a normal neural network (52). Skorput et al.
studied the effects of PAE on GABAergic interneurons in mice.
They found an increase in BrdU labeling in the medial ganglionic
eminence showing an increase in neurogenesis, as well as an
increase in parvalbumin-expressing GABAergic interneurons in
the medial pre-frontal cortex in adults. These results support the
contribution of GABAergic interneuron migration disorders to
persistent alterations in cortical development in adulthood (103).
In summary, migration is a set of complex processes regulated
by different molecular pathways that are disrupted in several
checkpoints when ethanol exposure occurs.
Differentiation
Processes of neuroblast differentiation initiate after neuronal
precursors have completed their last division and are ready
to migrate to a specific area (104–106). Depending on the
fate (brain area) of migration, neuronal precursors may
differentiate into neurons, astrocytes, or oligodendrocytes (107).
The differentiation of the cerebral cortex implies the formation of
laminae in the radial domain from the ventricular zone to the pial
surface and the subdivision of functional areas in the tangential
domain, in rostrocaudal and mediolateral axes. In this process,
the laminar fate is determined by cell-to-cell interactions and cell
autonomous restriction on their development (104).
Several proteins, used as biomarkers, are involved in the
differentiation processes. Doublecortin (DCX) has been studied
in depth as an endogenous marker of immature neurons.
The effects of pre-natal chronic ethanol consumption on adult
neurogenesis (PND 56) has been assessed in C57BL/6J mice,
revealing a decrease of DCX in the hippocampus after PAE
(82). Quantification of immature neurons labeled with DCX in
mouse was lower in the group of individuals exposed to alcohol
in the prenatal period compared to controls. Moreover, DCX
levels were lower in males than in females (108). Broadwater
et al. obtained similar results after PAE by oral gavage on
PND28–48, with decreased DCX levels in the DG of adolescent
mice. Furthermore, after interrupting ethanol exposure, reduced
levels of differentiated neurons in adulthood were found in rats
(109). Elibol-Can et al. observed slight changes in the number
of granular cells labeled with DCX in hippocampal DG on
PND 30. The authors reported a decrease in the volume of the
hippocampus in rats after a daily dose of 6 g/Kg ethanol during
second trimester equivalent (110). Likewise, Hamilton et al.
studied the long term-effects of single or continuous exposure
to alcohol during the third trimester equivalent in mice and the
effect of voluntary exercise as a therapy. Mice were exposed to
ethanol on PND 7 or PND 5, 7, and 9 and DCX measured in
adulthood. No differences in DCX levels were found in ethanol
exposed groups. Nevertheless, the group exposed to ethanol
during PND 5, 7, and 9 showed alterations in the results obtained
in Rotarod and passive avoidance behavioral tests, whichmeasure
motor coordination and memory, respectively (111). Conversely,
Coleman et al. observed increased levels of DCX after ethanol
exposure in the DG in adult PND 7 male mice, but not in
females (70).
Long-term effects of PAE have also been studied using
other biomarkers. Choi et al. assessed the effects of PAE on
BrdU levels in adult mice exposed to ethanol during the two
trimester equivalents. No differences in neuronal proliferation
nor differentiation were found after evaluating BrdU levels (31).
Boehme et al. studied BDNF levels of rats exposed to ethanol
during the three trimester equivalents. They found no changes
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in BDNF levels of animals exposed to ethanol in the prenatal
period. However, increased BDNF levels were observed in groups
assigned to voluntary exercise (35). Gil-Mohapel et al. reported
increases in NeuroD levels in adult rats exposed to ethanol during
the three trimester equivalents. The increase in differentiation
processes are probably due to the increase in immature neurons
showed in prenatally exposed groups (29). The changes observed
in the differentiation processes in adult rodents exposed to
ethanol during the prenatal period vary according to the used
biomarker. The increase in neuronal differentiation may occur
as a compensation of the cellular loss in fetal life.
Responsive element binding protein (CREB) and cAMP
signaling is directly correlated to neurogenesis, differentiation,
neuronal connectivity, and plasticity (112). Ethanol exposure
disrupts the activity of adenylyl cyclase (AC) reducing
cAMP/CREB signaling and therefore altering the differentiation
processes during neurodevelopment (112). In vivo and in vitro
studies have shown that acute alcohol exposure enhances agonist-
stimulated AC catalytic activity, while chronic alcohol exposure
produces adaptive changes in AC (113–115). Additionally,
GSK3β over-expression in neural cells disrupts CNS maturation
and differentiation processes in mouse at PND 60–120 (116).
The glial cell-derived neurotrophic factor (GDNF) is a
growth factor necessary for the development, differentiation,
proliferation, and function of midbrain dopaminergic neurons.
The GDNF signaling pathway is initiated by the binding of
GDNF to its co-receptor, GDNF family receptor-α 1 (GFRα1),
which leads to the recruitment of the RET receptor tyrosine
kinase. The activation of RET promotes the up-regulation of
downstream signaling pathways such as ERK1/2 (117) and P13K
(118), firing the activity of dopaminergic neurons. Moderate
administration of alcohol increases GDNF expression, exerting
a protective function against PAE. However, after acute (binge)
ethanol exposure in rats, GDNF expression decreases and its
protective function diminished (119). A recent study performed
in adult rats exposed to alcohol showed a decrease in DNA
methylation as the leading cause of GDNF epigenetic changes
following alcohol exposure (120).
Alcohol has deleterious effects on astrocytes despite them
being less susceptible than neurons to moderate alcohol
consumption (121). Glial cell alterations due to PAE lead to
changes in neuron-glia interactions, which causes developmental
defects of the brain (122). Glial fibrillary acidic protein (GFAP)
is a biomarker of mature astrocytes commonly evaluated in
differentiation processes during development. In vitro studies
using primary cultures of astrocytes from 21-day old fetuses
show initial increased values of GFAP levels post-ethanol
exposure (123), although these GFAP values decrease after 3
weeks (123). GFAP levels in rat neonates have been shown to
increase following ethanol exposure in different brain areas,
e.g., the hippocampus, cerebellum, and cortex as per different
administration routes (124–126). The results in in vitro models
suggest different effects of ethanol on astrocytes depending
on the neurodevelopmental stage. Moreover, some researchers
have found increased GFAP expression associated to gliosis
after chronic (moderate) and acute low ethanol exposures,
in mice (127, 128). These results indicate a high risk of
neurodevelopmental disease in acute PAE or heavy drinkers.
Conversely, no changes were observed in GFAP expression
after low chronic ethanol exposure (127). S100β is a classical
biomarker astrocytes, as the expression levels of S100β in these
glial cells is very high. During neurite outgrowth, S100β is
also secreted by proliferating astrocytes from cortical neurons.
The accumulation of this protein in mature glial cells is
associated with microtubule network and neurotrophic activity
(129). Reduced levels of S100β were reported in mice after
ethanol exposure (130), indicating a depletion in the number of
proliferating astrocytes and an impairment in the differentiation
processes. Otherwise, Sox2 and Oct4 transcription factors
regulate the embryonic stem cell pluripotency and the fate of cell
lineages by a narrow range of dose-effect (131). Excess of Oct4
compared to Sox2 leads cells to mesoendoderm differentiation,
while the other way round, i.e., higher levels of Sox2, promotes
neuroectoderm formation. Ethanol exposure of embryonic stem
cells in early differentiation generates imbalances between Oct4
and Sox2, which modifies the cellular fate from neuroectoderm
to mesoendoderm, altering the formation of the ectoderm
lineage and its derived progenitors. The Oct4/Sox2 imbalance
is considered one of the leading causes of developmental
delay and anatomical disabilities of the CNS observed in FAS
phenotypes (131).
Synaptogenesis
The developmental process of synaptogenesis involves
biochemical and morphological changes in pre- and post-
synaptic components. In rodents, maturation of synaptic
connections occurs during the postnatal period (Figure 1) (132)
and depends on the physicochemical compatibility of pre- and
post-synaptic components and the exclusion of inadequate
connections. Less harmful effects of alcohol exposure on
synaptogenesis have been observed when administered after
birth (54, 55), although during neuronal development ethanol
seriously alters some mechanisms related to synaptogenesis
(54, 55). In a study using a rat model in which individuals were
exposed to ethanol 4 weeks before and during pregnancy, the
ultrastructural analysis of the cerebellum at PND 7 showed
a delayed synaptogenesis and immature appearance of the
presynaptic grid (55). PAE affects the expression levels of
synaptic proteins such as synapsin 1 and of other proteins of
the pre-synaptic (GAP-43, synaptophysin, synaptotagmin) or
post-synaptic machinery (MAP 2 and neurogranin). Moreover,
ethanol interferes with the function of adhesion molecules such
as NCAM (in chick embryo model) (133) and L1 (in mouse
model) (134) involved in cell-cell interactions. During the neural
processes of migration and morphogenesis, both proteins are
involved in the organization and function of synaptic networks,
which determine neuronal plasticity. Several studies in animal
models (zebrafish) and cell cultures show decreased levels of
NCAM after ethanol exposure (135, 136). In other studies,
different patterns of NCAM expression were detected according
to the developmental stage on which PAE occurs (133) or the
NCAM isoform analyzed. For example, the highly sialylated
form of NCAM is overexpressed after ethanol exposure but the
NCAM 180 and NCAM 140 isoforms appear down-regulated in
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a rat model (137). Other studies in animal models (mice and rats)
have shown down-regulation of L1 following ethanol exposure
(134, 138).
Gliogenesis and Myelination
Glial cells provide nutrients and physical support to neurons
and regulate the presence of different proteins and components
in the extracellular fluid surrounding neurons and synapses
in the brain. They are essential for a normal development
and function of the central nervous system (139). Neuroblast
migration occurs through a scaffold provided by radial glia
(140). Microglia have macrophage functions and astrocytes
preserve the ionic and trophic balance of the extracellular
medium (141). Oligodendrocytes synthesize myelin, therefore,
this cell lineage preserves the myelin sheath and provides
trophic support (142). Schwann cells and oligodendrocytes are in
charge of the isolation and myelination of neuronal axons (143).
Oligodendrocyte progenitor cells proliferate and differentiate
into mature oligodendrocytes capable of myelinogenesis (144).
Thus, myelination begins later in neurodevelopment than other
processes such as proliferation and migration and progresses
throughout adolescence in rodents (145, 146). The development
of these cell lineages occurs at the same time as neurogenesis
in several areas of the central nervous system (141). These
lineages are characterized by distinct developmental stages and
sequential expression of different developmental biomarkers
such as the nerve growth factor (NGF), neurotrophins (NT-3
and NT-4), the brain derived neurotrophic factor (BDNF), and
the IGF-1 and IGF-2 factors. The BDNF is one of the most
studied neurotrophins. Alcohol alters the levels of BDNF and
its receptor tyrosine kinase B (TrkB). PAE induces decreased
levels of BDNF in the cortex and in the hippocampus in rats
at PND 7–8 (147). Some studies in rats show that TrkB levels
decrease in specific brain regions, e.g., in the hippocampus
(147, 148) and increase in the cortex (148). The BDNF and
its receptor are targets for ethanol damage. Consequently,
imbalances between them may contribute to the development of
FASD-like phenotypes, even in cases in which the levels of one
of them remain unaltered. In general, the up-regulation of these
neurotrophic factors show protective effects during development,
promoting myelination, cell survival, and neural regeneration in
pathological conditions (149).
Lancaster et al. showed that PAE reduces myelinogenesis and
its persistence after birth in a rat model (56). Severe impairments
in gliosis and a reduction of proteins related to myelin integrity
(myelin-associated glycoprotein, myelin basic protein, myelin
proteolipid protein, and myelin regulatory factor) was observed
in male adult mice exposed to a binge (acute) pattern of
PAE during gestation and lactation. This damage was followed
by behavioral alterations in executive function and motor
coordination (79). These changes could be associated to the
behavioral disabilities observed in FASD individuals. It has also
been shown that exposure to alcohol activates toll-like receptor 4
signaling pathways (MAPK, NFκB) in a mouse model, leading to
an increased expression of pro-inflammatory mediators (COX-
2, iNOS, HMGB1) and cytokines. Inflammation processes cause
myelinogenesis imbalances, impairments in synaptic links, and
activation of the cell death mechanism (150).
Trophic Support
CNS remodeling is a continuous process that not only takes
place during development, but also throughout adulthood in
response to environmental influences or genetically programmed
events. Alcohol alters synaptic plasticity and neural function
(151). Several proteins used as biomarkers participate in
neural plasticity processes. Histone deacetylase 2 alters the
GluN2A/GluN2B balance [the major subunits of functional
N-methyl-D-aspartate (NMDA) receptors] through changes in
GluN2B expression, which leads to memory-impairing effects
(152). The neurotrophin family of proteins includes NGF, BDNF,
NT-3, NT-4/5, and NT-6. It is well-known that NGF and
BDNF play important roles in PAE and FASD pathogenesis.
Various studies have shown that PAE disrupts neurotrophin
pathways, thus affecting the organogenesis and development
of brain structures in rodents (153, 154). NGF and BDNF
exert their biological effects by activating some members of the
tropomyosin-related kinase (Trk) family. NGF activates TrkA
and BDNF binds to TrkB (155). Stressful events, neurological
injuries, or neuroendocrine alterations in rats increase blood
levels of NGF (156). Thus, NGF expression and the functional
activity of NGF-target cells in the CNS are seriously affected
by alcohol consumption. BDNF regulates neural cell survival
and differentiation as well as several functions related to
neural plasticity such as learning and memory (157). A recent
study found that BDNF levels in the pre-frontal cortex were
significantly lower in the group of mice treated with ethanol in
comparison to the control group (158). The study concluded
that the impairment in learning and memory observed in
mice exposed to ethanol was associated to changes in BDNF
levels. Stragier et al. showed that chronic and moderate
alcohol consumption in C57BL/6J mice promotes a chromatin-
remodeling process, leading to up-regulation of BDNF signaling.
The authors suggest that this epigenetic regulation is an adaptive
process to balance cognitive disorders induced by alcohol (159).
Another study in mouse observed a reduction in ethanol
dependence after BDNF infusion in the pre-frontal cortex (160),
evidencing that BDNF levels in specific brain areas play a role in
alcohol dependence. Boehme et al. studied the changes produced
by voluntary exercise in hippocampal BDNF levels. Ethanol
was delivered by intragastric gavage during the three trimester
equivalents and individuals had free access to voluntary exercise
on a running wheel during adulthood. Results showed increased
BDNF levels in young adult females after voluntary exercise (35).
Recent studies suggest that matrix metalloproteinase-9 (MMP-
9), a Zn (2)+ dependent extracellular endopeptidase, participates
in neuronal plasticity, specifically in memory and learning (161,
162). Acute and chronic ethanol exposure up-regulates theMMP-
9 levels in the brain, particularly in the medial pre-frontal
cortex and hippocampus, in rats (163). The vascular endothelial
growth factor (VEGF) is involved in the activity, plasticity and
survival of microvessels. Mice prenatally exposed to alcohol
have reduced cortical vascular density, affected microvascular
structure, and altered expression of VEGF and its receptor.
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VEGF may prevent microvessel plasticity disorders and death.
As a mouse model shows, PAE exerts its deleterious effects on
the microvascular network, which suggests that vascular defects
contribute to alcohol-induced brain injury (164). In vitro studies
show that ethanol also alters the expression and function of
IGF-I and IGF-II, leading to birth defects such as low head
circumference at birth and microcephaly. These insulin-like
growth factors are used by the organism as a general signal
of cell survival, so that reduced IGF-I or IGF-II signaling by
PAE in neurons activates cell death mechanisms by apoptosis
or necrosis (165). Other biomarkers such as DYRK1A act as
general inhibitors of neural plasticity. Its over-expression in
different brain areas due to environmental insults or stress
conditions reduces neural plasticity in neurons promoting
cognitive problems and intellectual disability (166–168). Recent
studies have demonstrated that some DYRK1A inhibitors such as
the antioxidant Epigallocatechin gallate (EGCG) improve long-
term outcomes related with memory and executive function
in individuals with Down syndrome (166–168). Although it is
currently under study, the inhibition of DYRK1A could improve
the cognitive performance in pathologies associated to the loss of
neuronal functions and plasticity, e.g., FASD, Autism, or Down
Syndrome (169). Furthermore, EGCG increases NGF expression
by downregulation MMP-9. These proteins have been associated
with FASD alterations during neurodevelopment (170).
Synaptic Plasticity
Synaptic plasticity is the process through which long-term
changes in synaptic communication occur (171).
Fontaine et al. studied the effect of prenatal exposure to
ethanol in a rat model during the two trimester equivalent and
PND 21–28 on long-term potentiation, long-term depression,
and depotentiation in the medial perforant path input to the DG
of the hippocampus. Impairment of long-term potentiation was
seen in both males and females, while long-term depression was
only observed in males. The results suggest that PAE causes sex
specific impairment in synaptic plasticity in long-term depression
(172). Wong et al. focused their study in the contribution of
microglia in synaptic plasticity. Using a third trimester equivalent
mice model, ethanol was injected following a binge-drinking
pattern. The authors found a deficit in experience-dependent
synaptic plasticity in the visual cortex with no correlation to
microglial function (173). Shivakumar et al. administered ethanol
to mice at PND 7, and showed that ethanol exposure produces
epigenetic changes that inhibit the activation of several synaptic
plasticity genes. Coadministration of trichostatin A prevents
learning and memory disorders in adult mice (174).
PAE negatively affects synaptic plasticity. Epigenetic changes,
as well as damage to the microglia, may partially explain synaptic
plasticity disorders in FASD models.
Apoptosis
Apoptosis is a critical pathway in fetal neurodevelopment.
Programmed cell death systematically removes a large
number of neural precursors in embryonic structures formed
during development. PAE activates and deregulates cell
death mechanisms leading to the loss of cell lineages in the
hippocampus, basal ganglia, or cerebellum and disappearance
of critical structures in the brain such as the corpus callosum
(57, 58). The activation of apoptosis is produced by an increase of
reactive oxygen species (ROS) generated in ethanol metabolism
(see section Oxidative Stress). ROS activate intrinsic and extrinsic
apoptotic pathways, reducing the expression and function of
the anti-apoptotic proteins Bcl-xL and Bcl-2 in a rat model
(175). A study using a mouse model shows that the function of
the pro-apoptotic effectors Bak and Bax is directly influenced
by alcohol due to alterations in mitochondrial membrane
fluidity and dysfunctions in mitochondrial respiration, which
leads to the activation of the caspase cascade and subsequent
generation of the active form of the effector caspase 3 (176).
Consequently, some researchers have developed mitochondrial
protective strategies to prevent alcohol-induced damage.
Certain molecules, e.g., nicotinamide (177), can stabilize
mitochondrial membranes while others, e.g., antioxidants,
prevent mitochondrial dysfunction induced by the production
of ROS following ethanol exposure, in mouse. In addition,
ethanol activates specific cell death pathways. More specifically,
ethanol induces the phosphorylation of c-jun N-terminal-kinase,
a mitogen-activated protein kinase associated with apoptosis and
GDNF may interfere with the activation of the c-jun N-terminal-
kinase molecular pathway to prevent ethanol-induced apoptosis.
Unlike other neurotoxic substances, ethanol does not interfere
with the phosphorylation of the extracellular signal-regulated
kinases involved in the regulation of cell survival (178).
PATHOPHYSIOLOGY
There are multiple pathological effects derived from alcohol
exposure during fetal development depending on the studied
organ, region and cell type, as well as the stage of pregnancy
in which the fetus is exposed to ethanol (179). The following
sections provide a detailed description of the teratogenic effects
of PAE.
Oxidative Stress
Ethanol is metabolized in the liver of adult individuals via
the alcohol dehydrogenase (ADH) and aldehyde dehydrogenase
(ALDH) families of enzymes (Figure 3), leading to moderate
ROS production, e.g., hydrogen peroxide (H2O2) and hydroxyl
radicals (OH-). ROS are eliminated by endogenous antioxidant
mechanisms directed by catalase, superoxide dismutase (SOD)
and the antioxidant molecule glutathione (GSH) (180). After
a high intake of alcohol, the catalytic activity of ADH and
ALDH becomes saturated and an alternative pathway mediated
by the cytochrome P450 2E1 enzyme is up-regulated to
metabolize ethanol to acetaldehyde, producing high amounts
of ROS. ROS-sensing transcription factors, such as the nuclear
erythroid 2-related factor 2, activate the oxidative stress response
mechanisms when moderate levels of alcohol-derived ROS
are present, up-regulating antioxidant enzymes and proteins
involved in DNA repair. Imbalances between ROS-producing
pathways (following PAE) vs. the endogenous antioxidant
and DNA repair mechanisms promotes down-regulation of
detoxification pathways (180, 181). The decrease of the
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FIGURE 3 | Liver metabolic pathway of alcohol. ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; ROS, reactive oxygen species; SOD, Superoxide
Dismutase; GPX, Glutathione peroxidase; GR, Glutathione reductase. The ADH, ALDH enzymes and the P450 2E1 cytochrome participate in the oxidative
metabolism of alcohol. The activity of the P450 2E1 cytochrome in alcohol metabolism and the re-oxidation of NADH via the electron transport chain in the
mitochondria results in the formation of ROS. Catalase in peroxisomes, SOD in mitochondria and GPX-GR in cytosol are activated by an increase of oxidative stress to
reduce the levels of ROS. High amounts of ROS lead to a down-regulation (negative feedback) of the antioxidant response.
antioxidant system affects specific regions of the CNS such as
the cerebellum, hippocampus and cortex, as well as the placenta
(182, 183). The fetal brain is particularly sensitive to PAE because
the ADH isoform expressed in this tissue during development is a
class II isoenzyme ADH4. This isoform is less efficient for alcohol
catabolism than other isoforms expressed in adults (184). The
mechanisms involved in antioxidant response are physiologically
downregulated during development (185–188), contributing to
brain vulnerability by ethanol. The excess of ethanol also activates
the lactate pathway in the fetal liver, generating a deficit of
glucose in the bloodstream that affects especially the nervous
tissues (189). Imbalances of ROS activate the mechanisms of
inflammation (190) mediated by cytokines such as IL-6 or the
NLRP3 inflammasome, a multi-protein intracellular complex
responsible for processing and secreting the pro-inflammatory
cytokines IL-1β and IL-18 (191).
Tissue homeostasis is also affected by ROS (192), causing
changes in critical cell functions as signal transduction related to
the metabolism of macromolecules (lipids, proteins, RNA, and
DNA) (190). AS an example, ROS promote the modification
of 8-oxoguanine in DNA during embryogenesis (193, 194),
which is corrected by the enzyme oxoguanine glycosylase 1
(195). Calcium homeostasis and protein folding, modification
and secretion in endoplasmic reticulum are also altered by ROS,
as well as mitochondrial respiration, affecting its morphology
and function. Moreover, activation of autophagy, programmed
(apoptosis) and non-programmed (necrosis) cell death are also
promoted by oxidative stress (192, 196, 197).
Some studies have assessed the long-term consequences of
PAE on oxidative stress and the intracellular redox state. Dembele
et al. found an relation between continuous administration of
PAE with increased levels of oxidative stress in adult rats (PND
90), characterized by high levels of protein carbonyls, lipid
peroxides, high expression of SOD, and low levels of GSH (198).
Similar results have been reported by other authors, who showed
an association between chronic PAE at different concentrations
with increased levels of distinct oxidative stress and lipid
peroxidation markers in adolescent and adult rodents (199, 200).
Chu et al. found a correlation between PAE and apoptotic (p53)
and DNA oxidation markers (8-hydroxydeoxyguanosine) in
adult rats (200). Brocardo et al. reported depressive and anxiety-
like behaviors and high levels of lipid and protein peroxidation
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in adult rats (PND60) who were given ethanol throughout the
three-trimester equivalents (201). Their findings also indicate
an association between voluntary exercise, which increased the
endogenous antioxidant pathways in brain, and the reduction of
oxidative stress and depressive/anxiety-like behaviors. Similarly,
binge drinking model of PAE (GD 17–18) increased the levels
of lipid peroxidation and oxidative stress, apoptotic activation
via caspase-3 activity, and DNA fragmentation, decreasing
antioxidant molecules as GSH (202, 203).
Dysregulation of the Neuroimmune System
Ethanol exposure activates the innate neuroimmune system,
causing brain damage and neurodegeneration (150, 204). Alcohol
intake triggers the stimulation of microglia and astrocytes,
promoting neuroinflammation with the consequent production
of pro-inflammatory cytokines and chemokines (e.g., TNF-α,
IL-2, IL-6, IL-8, Il-10, IL-1RA, IFN-γ, or MCP-1) (150, 204).
Toll-like receptor 4 and NOD-like receptors have an
important function in glial cell stimulation and alcohol-
mediated neuroinflammation. Ethanol activates toll-like receptor
4 signaling pathways mediated by NFκB and MAPK, which
leads to the up-regulation of cytokines and pro-inflammatory
mediators such as HMGB1, COX-2, and iNOS (150). The
activation of these inflammation pathways generate severe
impairments on synaptic and myelin proteins as well as neural
damage (150). Moreover, the increased caspase-3 activity in the
prefrontal cortex indicates apoptotic cell death secondary to
PAE-related neuroinflammation (205). Regarding myelination
and white matter structure, PAE causes neuroimmune changes
such as reductions in myelin-associated glycoprotein levels,
myelin basic protein and myelin proteolipid protein. Alterations
in oligodendrocytes that interfere in the myelination process
affecting neural transmission and cognitive development have
also been described (79, 205).
Neurotransmitter Disorders
Neuronal cells and neuroanatomical structures are particularly
susceptible to toxic compounds during embryonic development,
explained by the high sensitivity of the processes during brain
formation. Neuronal damage triggers tissue degeneration by
inflammation and massive cell death (apoptosis and necrosis)
(182, 206). The loss of some progenitor cell lines seriously affects
proliferation, migration, and differentiation of mature neuronal
cells, essential to configure the distinct regions of the brain and
make them functional (207). The high sensitivity to increases
in oxidative stress is the main cause of cell death in these
parental lineages. This occurs because they lack the molecules
and enzymes required for an antioxidant response, i.e., catalase
and superoxide dismutase (181). High levels of ROS affect the
mitochondrial function in neurons and leads to the activation of
apoptosis (208).
In a prenatal ethanol-exposed brain, differentiation from
multipotent glial cells to astrocytes occurs prematurely,
preventing the correct completion of migration processes (209).
These astrocytes are therefore incorrectly located in the brain,
causing motor, and cognitive disorders, promoting cell death of
these neuronal groups and triggering harmful effects such as the
agenesis of the corpus callosum (209). Moreover, primary cultures
of hippocampal neurons exposed to ethanol show reduced levels
of the glucose transporter GLU1 necessary for the correct growth
and development of most cell types present in the brain whose
main carbon source is glucose (210). Alcohol also alters the
levels of neurotransmitters, namely serotonin, dopamine, and
glutamate (211). Exposure to alcohol delays serotonin synthesis,
blocking the stimulation of astrocytes and the release of the
growth factors needed for proper neurodevelopment (212).
Ethanol reduces the number of glutamate receptors (NMDA),
which in turn affects other neurotransmitter routes generating
important alterations in the transmission of nerve signals (213).
The acetaldehyde produced by the metabolism of local ethanol
in fetal hippocampus inhibits neurosteroid synthesis and blocks
NMDA receptors in pyramidal neurons, contributing to synaptic
dysfunction associated with severe alcohol intoxication (214).
Furthermore, a recent in vitro study with rat brain slices exposed
to 70mM ethanol indicates that the combined overexpression
of GABA receptors and inhibition of NMDA receptors results
in alcohol-induced neurodegeneration during synaptogenesis
(215). Consequently, the administration of single doses of an
NMDA antagonist in Sprague Dawley rats causes apoptotic
neurodegeneration in young animals, although no impairments
were identified in adult individuals. Therefore, the NMDA
antagonist acts on the CNS in a similar way ethanol does (216).
PAE has neuroapoptotic effects on the up-regulation of
GABAergic transmission and deficit of NMDA receptors.
The impairment produced by ethanol on developing neurons
depends on the specific neural lineage and is age-dependent.
A study performed in mice exposed to moderate amounts of
alcohol showed that the subunits of NMDA receptors GluN1
and GluN3A are up-regulated after PAE in the DG. The
study also found a decrease of GluN2B levels in the synaptic
membrane (217).
Epigenetic Modifications
During fetal development, epigenetic mechanisms establish
the whole pattern of gene expression for the tissues, organs
and cell types that constitute the complete organism. These
mechanisms involve the methylation of DNA, modifications of
N-terminal tails in histones, and the regulation of micro and
non-coding RNA.
InDNAmethylation, methyl groups (CH3), a product of folate
metabolism, are added to the cytosines (C) present in the regions
known as CpG islands of the DNA helix. This phenomenon
is mediated by methyl-transferases (DNMT) and demethylases
such as TET2 (218). DNMT3a and 3b set the complete genome
expression patterns during fetal development and DNMT1
maintains this pattern in postnatal stages (219). Usually, the
clusters of CpG islands match with promoter regions to regulate
the expression of the genes involved in a specific pathway or
signaling (220). In general, methylation is associated with gene
silencing and demethylation with active transcription. Histones
regulate the dynamics of chromatin in remodeling processes
between heterochromatin, inaccessible to DNA polymerases,
and the expanded chromatin (euchromatin) that allows gene
expression. Histone structure and function is regulated through
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FIGURE 4 | Facial dysmorphology induced by prenatal ethanol exposure. Representative examples of a control animal (A) and a fetus severely affected by ethanol
exposure (B). FAS-like phenotype (B) is defined by microcephaly, short palpebral fissures, thin upper vermillion, and smooth philtrum. FAS-like facial features are
induced in the mouse by maternal alcohol exposure on gestational day 7 and 8.5 (equivalent to the third gestational week in humans). Courtesy of Prof. Kathie Sulik,
University of North Carolina-Chapel Hill (271) (https://www.teratology.org/primer/fas.asp).
different post-translational modifications in their N-terminal tail
such as methylation, acetylation, and phosphorylation, mainly in
the amino acids lysine, arginine, and serine. All these reversible
modifications are carried out by different enzymes such as
kinases, acetyl-transferases or methyl-transferases depending on
the requirements of the cell (221). Otherwise, non-coding and
microRNAs regulate protein translation and mRNA stability,
acting post-transcriptionally as inhibitors of mRNA by direct
interaction (222).
Ethanol and ROS canmodify the activity ofmethyltransferases
and demethylases, directly affecting the global DNA methylation
pattern during development. A recent study performed in mice
after PAE found 118 differentially methylated regions (DMRs)
related to transcription factor binding sites (223). The pathways
affected by these DMRs were epigenetic remodeling, hormonal
signaling, metabolism, and immune response, revealing
persistent occurrence of these alterations in all developmental
stages (223). Demethylation following ethanol exposure causes a
decrease in IGF-2 levels in utero, generating an important delay
in growth and leading to skeletal malformations (224).
PAE influences the activity of enzymes such as histone
acetyltransferase and histone deacetylase, which modify the
composition of the amino-terminal tails in histones (225).
Moreover, the acetylation of histones H3 and H4 has been
directly related to alterations in the development of the
cerebellum, cardiac defects, and hepatic damage (226, 227).
Cantacorps et al. (228) showed that a binge PAE pattern in
mice alters histone acetylation (lysine 5 and 12 in histone
H4) in the pre-frontal cortex and the hippocampus. These
long-term epigenetic modifications are associated with cognitive
and behavioral impairments in offspring. Ethanol exposure
alters the expression pattern during development, affecting
non-coding and microRNAs expression (229). PAE generates
a decrease in the expression of miR135, miR9, miR21, and
miR355. The absence and deregulation of these microRNAs
generate early maturation of the progenitor stem cells and an
increase in cell apoptosis, producing severe impairments in fetal
brain development (230). The high variability of the described
epigenetic changes is associated to the dose of ethanol received,
the time of exposure and the gestational stage in which alcohol
intake occurs.
DIAGNOSIS OF FASD
PAE results in a wide range of phenotypic manifestations and
behavioral deficits in the offspring we describe below.
Craniofacial Anomalies
The key facial features used for a clinical diagnosis of FAS in
humans include short palpebral fissures, a thin upper vermilion,
and a smooth philtrum (231). Considering previous studies in
humans (232, 233), Fang et al. described, for first time in 2009,
a validated facial image analysis method based on a multi-
angle image classification using micro-video images of mouse
embryos. This method, validated later by other researchers,
allows discerning between embryos that have been exposed or not
to ethanol (232, 233). Rodents provide not only a validatedmodel
to study how PAE alters morphogenetic processes, but it also
allows making an association between a facial feature alteration
and the structure/function in the CNS.
Alcohol exposure during essential periods of embryonic
development results in craniofacial dysmorphology (Figure 4).
Several studies have used chick and murine PAE models to
demonstrate the correlation between craniofacial anomalies,
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apoptosis induction, and altered migration of neural crest cells
(234–236). A series of facial anomalies may present in FASD
associated to PAE during the premigratory period of neural crest
cells (Figure 2). At this stage, ethanol induces calcium transients
that activate CaMKII that mediates the loss of transcriptionally
active β-catenin, which produces the apoptosis of populations
of neural crest cells. Genetic factors play an important role in
the vulnerability to alcohol-induced craniofacial dysmorphology.
Sonic Hedgehog signaling, platelet-derived growth factor subunit
A, Vang-like protein 2, or ribosomal biogenesis genes are of
special importance in neural crest development (237). Studies
using FASD-like phenotype rodent models, in which dose
and timing of ethanol exposure is controlled, show structural
alterations in head and face (238, 239) similar to anomalies
observed in humans (240).
Several studies have examined the craniofacial anomalies
in FASD-like rodent models. According to Godin et al.,
intraperitoneal administration of two injections of ethanol at
2.9 g/Kg in mice on GD 7 (equivalent to post-fertilization week
3 in humans), generates a series of facial dysmorphologies
similar to those seen in FAS children. These defects include
median facial cleft, cleft palate, micrognathia, pituitary agenesis,
and third ventricular dilatation and heterotopias (33). However,
intraperitoneal alcohol exposure of two 25% dosages of ethanol
at 2.9 g/Kg delayed to GD 8.5 in mice produces a different
pattern of dysmorphologies such as shortening of the palpebral
fissures, mild hypoplasia and shortened upper lip, but a
preserved philtrum (60). Variations in FAS-like facial phenotypes
depend on exposure timing, implying different facial features
when considering this variable (Figure 2). New techniques
for FASD diagnosis include methods to identify potentially
at-risk individuals based on the identification of subtle and
subclinical facial characteristics (241). Scientists have developed
a computerized system for detecting facial characteristics using
three-dimensional facial imaging and computer-based dense-
surface modeling (241, 242). This approach has been compared
against standard dysmorphology physical examination for FAS
diagnosis revealing high similarities (243). More recently, new
techniques based on MicroCT 3D scan performed on pups
prenatally exposed to alcohol have been developed (244). This
method showed that craniofacial bones might be a reliable and
sensitive indicator of PAE in mouse pups exposed to 4.2%
alcohol v/v for 2 weeks before the pregnancy and GD 7–16.
The same study also confirmed that the neurocranium (cranial
skeleton) is more sensitive to alcohol than the viscerocranium
(facial skeleton). Other researchers characterized concurrent
face-brain phenotypes in mouse fetuses exposed to two 25%
intraperitoneal dosages of ethanol at 2.9 g/Kg on GD 7 or
GD 8.5 and using MRI imaging and dense surface modeling-
based shape analysis (60). Differences in facial phenotype linked
to GD of ethanol exposure were found, being more subtle
when the exposure was on GD 8.5. Both phenotypes were
associated with unique volumetric and shape abnormalities of
the septal region, pituitary, and olfactory bulbs. These findings
illustrate the need of increasing the current diagnostic criteria to
better capture the full range of facial and brain dysmorphology
in FASD.
Brain and Neurobehavioral Deficits
Brain organogenesis is the most severely affected process by
alcohol exposure (245) and there is a general consensus in
relation to the effects of PAE on the hippocampus, cerebellum,
and the corpus callosum (246, 247). Important asymmetry of the
hippocampus is observed in FAS children, with the left lobe being
smaller than the right lobe (8). The cerebellum, associated with
balance, coordination and learning capacity, and the anterior part
of the vermis develop hypoplasia when exposed to ethanol (7).
The corpus callosum is particularly vulnerable to ethanol
exposure and, in some cases, may lead to total (agenesis) or partial
(hypoplasia) loss of structure (248). Themost affected areas of the
corpus callosum areas are the front (genu) and back (splenium
and isthmus), appearing smaller and displaced from the usual
spatial location in the brain (6). Basal ganglia is responsible
for motor and cognitive abilities, presenting a smaller size in
patients with FAS, particularly the area of the caudal nucleus
associated to cognitive abilities such as spatial capacity (249).
A recent study using three-dimensional surface MRI techniques
showed abnormalities in the cortical folding (gyrification) of
FASD children. These findings are directly correlated with IQ
(250). Future research with MRI techniques to evaluate rodent
gyrification may prove to be useful to increase the knowledge on
the relationship between cortical development involvement and
cognitive disorders in humans.
Broadly, the timing of the ethanol exposure (251) has a clear
impact on the CNS and elicits specific brain and behavioral
deficits and disorders in motor and cognitive functions (14)
(Figure 2).
Different standardized tests in rodents have been used
to assess FASD-related abnormalities. As the hippocampus
is one of the most damages structures when exposed to
ethanol, most studies assessed hippocampal function. Spatial
learning is commonly evaluated to demonstrate hippocampal
disorders (45, 79, 252). Different authors describe long-
term motor coordination impairments, learning and memory
deficiencies in adult male mice prenatally exposed to alcohol
(79), behavioral effects in rats following short-term PAE (253),
or depressive-like behaviors in adult rats exposed to ethanol
across the three-trimester equivalents (201). To identify the
outcomes of gestational alcohol exposure, a summary of
behavioral characteristics after alcohol exposure is needed.
Table 2 summarizes the standardized behavioral tests used in
rodents to analyze the harmful effects of PAE.
Fetal Growth Restriction
Ethanol interference with maternal nutrition may differ. As a
source of energy, alcohol blocks the absorption of other nutrients,
including proteins, and hinders intestinal transport of essential
nutrients. Due to its effects on liver, alcohol causes metabolic and
nutrient utilization alterations. PAE causes maternal nutritional
deficiencies that result in fetal growth deficiencies (26).
PAE also impairs placental angiogenesis (269) and
consequently fetal growth restriction (FGR) (270). The growth
curves defined by Dilworth et al. are a useful tool to define the
frequency distribution of mouse weight. Any fetus with a weight
below the fifth centile was considered growth restricted (68).
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TABLE 2 | Standardized experimental methodologies for assessing behavioral effects of prenatal alcohol exposure in murine models.




Motor hyperactivity, poor motor
coordination, altered accuracy of
saccadic eye movements, and
deficits in postural balance are
impaired motor skills observed in
individuals exposed to ethanol
during early life.
PAE-related motor deficits are
more apparent in early life than
in adulthood.
The rotarod (79) For this test, a bar that can rotate at an
accelerated or a fixed speed is used. The
latency of the fall of the rodent placed in the bar
is measured. Measurements provide an idea of
motor coordination.
Swimming test (255) It consists of a Perspex tank where rodents are
placed and must swim to an escape platform.
The sequence is recorded and later analyzed to
assess the latency to reach the platform and
the number of fore and hind limb strokes.
Raised beam test Rodents are placed on the bar and their ability
to cross it is measured along with paw slips
and traverse time. It provides an indication of
their balance.
Footprint analysis After their paws are painted or dipped in ink,
rodents leave a trail of footprints when they
walk or run along a corridor to a goal box.
Measurements of stride length, base width,
and fore and hind paws overlap give an
indication of gait. Automated versions of the
task use video processing of footage taken




Hippocampal cell loss, altered
neuronal morphology, decreased
synaptic density, and reduced
trophic support.
Simple maze task (258, 259) A T-maze (or the variant Y-maze) is a simple
maze used in animal cognition experiments. It
is shaped like the letter T (or Y), providing the
subject, typically a rodent, with a
straightforward choice. T-mazes are used to
study how rodents function with memory and
spatial learning by applying different stimuli. The
different tasks, such as left-right discrimination
and forced alternation, are mainly used with
rodents to test reference and working memory.
Morris water maze (71, 252) MWM is a test of spatial learning for rodents
that relies on distal cues to navigate from a
start point around the perimeter of an open
swimming box to locate a submerged escape
platform. The test allows measuring spatial
learning and reference memory.
Fear conditioning (260) This test is a form of Pavlovian learning based
on the conditioning of an innate response to
fear consisting in a complete lack of
movements. During an initial phase, the animal
is exposed to a conditioned stimulus paired
with an aversive experience (unconditioned
stimulus). The test measures the fear response
in mice replaced in the same location with and
without the previous stimulus.
Object recognition (79, 261) In an initial session, the rodent is presented
with two similar objects. One of the objects is
replaced by a new object in the second
session. The test measures the amount of time
taken to explore the new object.
(Continued)
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TABLE 1 | Continued




Disorders in cognitive control of
behavior, including basic
cognitive processes such as
attentional control, cognitive
inhibition, inhibitory control,
working memory, and cognitive
flexibility.
Passive avoidance (263) Mice learn to inhibit the natural tendency to
explore new environments where a negative
stimulus was previously obtained.
The test consists of a chamber divided in two
compartments separated by a gate. Animals
are allowed to explore both compartments in
the initial phase. In the following phase, they
obtain a negative stimulus in one of the
compartments. Animals will learn to associate
certain properties of the chamber with the
negative stimulus. The test measures the
latency to cross the gate between the two
compartments when the animal is placed in the
compartment where no aversive stimulus
were obtained.
Simple maze task (258, 259) See description in learning and memory.
Morris water maze
(71, 252, 264)
See description in learning and memory.
Prepulse inhibition (265) PPI is a neurological phenomenon in which a
soft pre-stimulus (pre-pulse) inhibits the
reaction of the animal to a subsequent strong
stimulus (pulse) often using the startle reflex.
Stimuli may be acoustic, tactile, or luminous.
Social behavior (251) Poor social skills and
inappropriate social interactions.
Observation (251) Feeding difficulties in neonates and lack of
parental care.
Aggressive behaviors in adults and reversed
behaviors between males and females.
Affective behavior (201) Anxiety- and depressive-like
behaviors (201)
Elevated-plus maze (266) The device is made up of open arms and
closed arms, crossed in the middle
perpendicularly to each other. Mice have
access to all of the arms. The number of
entries into the open arms and the time spent
in each arm are used as a measure of
anxiety-like behavior.
Forced-swim test (267) The test is based on the assumption that an
animal placed in a container filled with water
will try to escape. However, it will eventually
exhibit immobility that may be considered a
measure of depressive-like behavior.
Olfaction (253) Injury of the olfactory circuits. Classical conditioning tasks
(268)
An odor is paired with a tempting or aversive
stimulus and the response of the animal to the
odor is followed by the tester.
PAE, prenatal alcohol exposure.
Middaugh et al. characterized the impaired growth of C57BL/6
mice prenatally exposed to alcohol (271) showing the influence
of alcohol on fetal growth when administered in the second and
third trimester equivalents (271, 272).
Other authors have described the effects of ethanol on
trophoblasts and placental permeability. Gundogan showed an
altered branching morphogenesis in the labyrinthine zone and
the suppression of invasive trophoblastic precursors. This altered
process compromised fetal growth and placentation in a dose-
response manner (69). The permeability inducer VEGF was
up-regulated in mouse placenta after acute alcohol exposure.
Permeability was also affected by altered structures in the barriers
that separate feto-maternal blood circulation (273). Therefore,
altered growth factors in conjunction with malformations of the
placental barrier may contribute to placental malfunction and
permeability alterations in the feto-maternal barrier.
Biomarkers for PAE
A biomarker is objectively measured and assessed as an indicator
of a normal biological or pathogenic process, or a pharmacologic
response to a therapeutic intervention (274). Here we will use
the term biomarker as the molecular or genetic indicator that
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identifies prenatal exposure to ethanol. In murine models, the
researcher controls the dose and timing of alcohol exposure and
eliminates other variables (e.g., other drugs) that may skew the
results. This, and the possibility of getting multiple matrices
from the rodents, will allow to obtain appropriate biomarkers for
PAE detection.
Some authors have demonstrated a significant decrease of
alpha-fetoprotein, a perinatal stress biomarker, in the amniotic
fluid of B6J litters exposed to alcohol on Day 8 of gestation,
although no differences were found in the B6N substrain (275).
Other biomarkers, such as fatty acid ethyl esters (FAEEs), a
product of non-oxidative ethanol metabolism and a validated
biomarker for PAE, have been detected in mouse heart, liver,
placenta, and fetal tissues, 1 h after maternal ethanol exposure.
FAEEs were shown to persist for at least seven days in the
placenta of the mice and at least 14 days in fetal rat organs
(276). Unfortunately, FAEEs cannot be measured in neonatal
rodents due to the lack of neonatal hair. By contrast, guinea pigs
allow a good approximation since they are born with hair (277).
Some authors have shown that FAEE concentrations in exposed
offspring samples taken at PND 1 were more than 15-fold higher
than their control counterparts (278).
On the other hand, changes in selective neurotransmitters
from fetal brains of prenatal alcohol-treated C57BL/6 mice
were also observed. Authors showed significant reductions in
dopamine, norepinephrine, epinephrine, serotonin, and GABA
levels in E13 fetal brains. These results would explain the main
causes of abnormalities in brain function and behavior found in
fetal alcohol spectrum disorders (279).
In recent years, epigenetic studies in rodents highlight the
potential of DNA methylation, histone modification, or non-
coding RNA species as biomarkers of PAE. Most of these studies
have evaluated general changes for each epigenetic modification.
DNA methylation has been the most analyzed marker for PAE-
induced epigenetic dysregulation, showing that PAE promotes
a global pattern of hypomethylation on fetal DNA during
pregnancy affecting critical genes such as bdnf (280). Haycock
et al. demonstrated that genomic imprinting was also deregulated
by PAE, in mouse embryos (281). Low levels of igf2 expression
correlates with PAE due to a specific CpG hypomethylation found
in its promoter region (224). Pomc expression in neurons, related
to stress response, is also reduced by CpG hypermethylation in
its promoter (282). The authors suggest that this alteration can be
transmitted to offspring, raising the hypothesis that the effect of
PAE not only occurs when the fetus is exposed to alcohol but also
throughout its whole life and future progeny. Hence, the use of
these epigenetic changes using CpG methylations as biomarkers
of PAE may be a challenge to consider.
Regarding histone modifications, several studies have
found PAE-specific alterations on PAE on H3K9ac, H3K4me2,
H3K27me3, and H3K9me2, particularly in the brain. These
changes are related to alcohol response mechanisms, e.g.,
H3K9ac, which has been shown to increase after PAE down-
regulates genes related to alcohol response (283, 284). Moreover,
the increase of H3K4me2 promotes the up-regulation of
genes related to alcohol response (284). A general increase
of H3K27me2 was observed in the brain in response to PAE
(285), more specifically in the hippocampus and neocortex.
H3K9me2 also increased after alcohol exposure suggesting
persistent alterations in the expression pattern for a long period,
and as such has it being considered as a potential biomarker of
PAE (286).
Alterations in non-coding RNA expression following PAE
have been assessed in rodents. Results show that PAE causes the
suppression of several miRNA such as miR-21 and miR335 in
fetal neuronal and progenitor stem cells (230, 287). PAE also
suppresses the expression of miR-9 and miR-153 and increases
the levels of miR-10a during pregnancy (287, 288). Similar
results have been reported in zebrafish after PAE (289) and in
a rodent model of alcohol use disorder (290). However, due
to the heterogeneity, the low reproducibility and the lack of
correlations in the results from the different studies, no consensus
has been reached for non-coding RNA, showing the complexity
of epigenetic interactions when they are altered by PAE.
Animal models play an important role in the identification
and validation of new candidate biomarkers, e.g., selective
neurotrasmitters, igf1, igf2, and miRNA. In humans, only
the direct biomarkers fatty acid FAEEs, ethyl glucuronide,
ethyl sulfate, and phosphatidylethanol in biological matrices
are validated to detect PAE (291). The low levels of igf2
expression after PAE (224) in mouse are in line with the
results of a recent publication that compared the levels of
IGF I and IGF II in the FASD pediatric population with
children objectively non-exposed to ethanol (292). These results
highlight the potential use of IGF-I and IGF-II as surrogate
biomarkers of the damage induced by PAE. Furthermore, BDNF
levels in rodent models are known to be disrupted during
acute/chronic and prenatal alcohol consumption (293). Thus,
changes of BDNF levels in the meconium, cord blood, or in
the mother’s/infant’s serum are used as potential biomarkers of
PAE in humans based on rodents results (293, 294). Moreover,
magnetic resonance spectroscopy studies in rodents have shown
that neurotransmitter biomarkers of FAS including choline,
acetyl choline, N-acetyl aspartate, and glutamate, a precursor for
the synthesis of GABA, are significantly reduced in FAS (295).
Reduced levels of glutamate, taurine, and N-methyl D-aspartic
acid receptor have also been observed in FAS children (296, 297).
PAE alters the methionine-homocysteine pathway in rodents and
humans. Thus, s-adenosylmethionine, which acts as donor of
methyl groups to DNA methylases, may be a promising clinical
biomarker of FASD (298).
DISCUSSION
FASD is a growing problem in our society. Diagnostic difficulties,
limited knowledge on the underlying mechanisms of ethanol
toxicity, and absence of effective strategies to treat this pathology
is a serious medical matter. There is a wide range of FASD-
like animal models, and researchers must be very precise and
choose the one that suits best the objective of the study.
Invertebrates and simple vertebrates allow alcohol exposure
and the assessment of physical malformations and simple
behaviors at different developmental periods (299). However,
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when studying brain structures or complex behaviors, mammals
offer significant advantages compared to the above mentioned
models (19). Further insights on FASD is possible with murine
models as they allow evaluating the specificity of dose-dependent
alcohol teratogenic effects, the timing and developmental stage
of fetuses, brain structures, and complex behaviors. Rodents
are useful for exploring promising treatments that may help
minimize the effects of PAE. C57BL/6 mice are one of the
most commonly used mammals in FASD research because
they are easy to handle when searching for malformations or
complex behaviors after alcohol exposure. Awide range of precise
methodologies and experimental protocols have been performed
using these animal models. In this review, we have described and
compared these protocols to provide a framework that allows
researchers to make the correct choice of animal model in their
research project.
Rodents and humans have similar stages of brain
development, differing in birth timing. The third trimester
equivalent in rodents is postnatal. It seems clear that facial
dysmorphology appears when ethanol exposure occurs
during first trimester equivalent (33, 60, 236, 300). However,
it is difficult to establish the optimal period for ethanol
exposure when brain and behavioral alterations are explored,
because brain developmental processes occur continuously
throughout the second and third trimester equivalent.
The criteria to choose an appropriate FAS-like model will
depend on the experimental design and research questions,
for which different patterns of alcohol exposure, tissue
analysis, molecular mechanisms, or cell types assessment
will be needed.
The pattern of ethanol exposure and dosages are important
parameters. Some studies support the hypothesis that a lower
daily dose of alcohol administered in a binge-like pattern results
in lower brain weight and greater cell loss than a higher daily dose
administered in a non-binge-like pattern, as binge-like patterns
lead to higher BAC peaks (24, 301).
It is essential to identify FASD manifestations in the
experimental models to reach the objectives of the research.
Different biomarkers are involved in the distinct stages of
brain development (summarized in Figure 1), which can be
of help when studying the effects of ethanol intake during
pregnancy. FAS biomarkers are useful to evaluate the effects of
experimental therapies. There is a wide spectrum of techniques
to assess facial dysmorphology, e.g., the validated facial image
analysis method based on a multi-angle image classification
using micro-video images of mouse embryos (233), and other
experimental novel techniques based on MicroCT 3D (244).
To assess neurodevelopment and behavior of FASD-like rodent
models, several standardized behavioral measurements have
been described (302, 303) (summarized in Table 2), which
allow evaluating the different spheres affected by PAE. When
choosing the most appropriate test, the skills the researcher
wants to analyze must be taken into consideration. The Morris
water maze allows an accurate evaluation of a set of cognitive
and motor behaviors affected by PAE. It is necessary to
underline the existence of other useful alternatives to evaluate
these behaviors.
Fetal growth is impaired by the harmful effects alcohol exerts
on angiogenesis. Fetal growth restriction may be evaluated
through standardized fetal measurements in defined frequency
distribution curves (68), or by assessing the placenta using
biomarkers and histopathological analysis.
The use of animal models results essential in pre-clinical
studies to evaluate the toxicity of potential pharmacological
tools. Animal models also provide an insight into the molecular
mechanisms altered by alcohol as per the developmental
timing of exposure, pattern of exposure, and dosage. Thus,
any experimental breakthrough may be directly applied in
clinical care to improve the diagnosis and treatment of
FASD patients.
This review contains updated information on FAS-like model
in rodents, aiming to be a useful reference for researchers
working with FASD-like murine models. This is not a systematic
review, although we have performed an in-depth narrative
review on the topic. We have reviewed methodologies and
protocols as per the objectives of the study in order to
obtain robust conclusions for future studies. This work will
facilitate decision-making when designing a FASD experiment
in rodents by exploring and summarizing the currently available
information on prenatal alcohol effects in each pregnancy
equivalent trimester.
Additional knowledge on cellular, biochemical, genetic
and molecular mechanisms, and pathways altered by PAE
is necessary. This will allow further experimental research
with murine models aiming to improve diagnostic strategies,
prevention and treatment for alcohol-related problems.
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